Indication
- For the topical treatment of actinic keratosis of the face or scalp
Last updated on 12/18/2020Document Title | Year | Source |
A phase 3, double-blind, vehicle-controlled, randomized, parallel group, multicenter, efficacy and safety study of KX2-391 ointment 1% in adult subjects with actinic keratosis on the face or scalp (AK003). | 2020 | Athenex, Inc. |
A phase 3, double-blind, vehicle-controlled, randomized, parallel group, multicenter, efficacy and safety study of KX2-391 ointment 1% in adult subjects with actinic keratosis on the face or scalp (AK004). | 2020 | Athenex, Inc. |